KCM
ZBH icon

Kames Capital Management’s Zimmer Biomet ZBH Stock Holding History

Kames Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,634
Closed -$1.58M – 192
2014
Q2 		$1.58M Sell
15,634
-6,724
-30% -$656K 0.05% 117
2014
Q1 		$2.05M Hold
22,358
– – 0.06% 105
2013
Q4 		$2.02M Buy
22,358
+5,672
+34% +$491K 0.07% 107
2013
Q3 		$1.33M Buy
+16,686
New +$1.31M 0.04% 140

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Kames Capital Management's ZBH Position: Q3 2014 in Review

Kames Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2014, closing a stake of 15,634 shares — an estimated $1.58M sold.

Kames Capital Management first reported a position in ZBH in Q3 2013 and held it in 4 quarters. The position peaked at $2.05M in Q1 2014. 720 funds tracked by Wall St. Rank hold ZBH as of Q3 2014.

  • Kames Capital Management reported no remaining Zimmer Biomet position as of Q3 2014 after selling out during the quarter.
  • Kames Capital Management sold 15,634 Zimmer Biomet shares in Q3 2014, an estimated $1.58M.
  • Kames Capital Management first reported a position in Zimmer Biomet in Q3 2013 and held it in 4 quarters.
  • Kames Capital Management's Zimmer Biomet position peaked at $2.05M in Q1 2014.
  • 720 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2014.

Based on Kames Capital Management's 13F filing for Q3 2014, filed 20 Oct 2014.